Science

Rheumatoid arthritis patients under treatment with methotrexate

Rheumatoid arthritis patients under treatment with methotrexate

Patients with rheumatoid arthritis (RA) often suffer from what is referred to as interstitial lung disease (ILD). For years, standard medication with Methotrexate (MTX) has been suspected of either increasing the risk of, or worsening, this aspect of rheumatoid arthritis. This suspicion is now refuted by two current studies. The results have been presented at the annual conference of the European League Against Rheumatism (EULAR 2020).

Read More…….
EurekAlert!, the online, global news service operated by AAAS, the science society,